Skip to main content

Table 1 Summary of changes in signaling components between normal and CRC tissues

From: High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer

Signaling component

Normal

CRC II

CRC IV

Comment

EGFR

+

+

+

Similar levels in benign, CRC II and IV.

pAKT/AKT

+

+

+

Total levels of pAKT and AKT upregulated in CRC but pAKT/AKT ratios were similar in the different samples.

p70S6K

+

+

+

Similar levels in benign, CRC II and IV.

PLCγ1

-

+++

+ +

Low or no PLCγ1 expression in benign samples and higher levels in CRC. pPLCγ1 was not detected in any samples.

SRC pY527/SRC

+++

+

+

Low or no SRC pY418 in all samples. Lower SRC pY527/SRC ratios in CRC II and IV compared to benign.

pERK1/ERK1

+++

+

+

Reduced pERK1/ERK1 ratio in CRC II and IV compared to benign.

pERK2/ERK2

++

++

++

Similar ratios benign, CRC II and IV.

MEK1/2

+

+

+

Similar levels in benign, CRC II and IV.

  1. +, ++ and +++ indicate different relative levels or ratios for a particular signaling component when comparing normal, CRCII and CRCIV samples, and should not be applied to compare levels/ratios between the different signaling components